Ongoing myocardial damage relates to cardiac sympathetic nervous disintegrity in patients with heart failure
Ongoing myocardial damage relates to cardiac sympathetic nervous disintegrity in patients with heart failure
复制标题
DOI:
10.1007/bf02985045
复制
发表时间:
2005-10-01
影响因子:
2.6
通讯作者:
Kubota, I
中科院分区:
文献类型:
--
作者:
Arimoto, T;Takeishi, Y;Kubota, I
Iodine-123-metaiodobenzylguanidine (I-123-MIBG) has been used to assess the integrity and function of the cardiac sympathetic nervous system in patients with heart failure. Heart-type fatty acid binding protein (H-FABP) is released into the circulation when the myocardium is injured, and H-FABP has been recently used as a novel marker for the diagnosis of ongoing myocardial damage. Objective: The aim of the present study was to compare cardiac sympathetic nervous activity assessed by I-123-MIBG imaging with serum levels of H-FABP in patients with heart failure. Methods: Fifty patients with chronic heart failure were studied. I-123-MIBG imaging was carried out at 30 min (early) and 240 min (delayed) after the tracer injection. We measured serum levels of H-FABP using a sandwich enzyme linked immunosorbent assay. Results: Heart to mediastinum (H/M) ratios of I-123-MIBG decreased and washout rate increased with higher New York Heart Association (NYHA) functional class. H-FABP, norepinephrine and brain natriuretic peptide (BNP) levels increased as the severity of NYHA class advanced. Delayed H/M ratio was significantly correlated with H-FABP (r = -0.296, p = 0.029) and BNP (r = -0.335, p = 0.0213). Myocardial washout rate of I-123-MIBG was also correlated with H-FABP (r = 0.469, p < 0.001), norepinephrine (r = 0.433, p = 0.005), and BNP (r = 0.465, p = 0.001). Conclusions: These data suggest that cardiac sympathetic nervous activation was associated with ongoing cardiomyocyte damage characterized by an elevated serum level of H-FABP in patients with heart failure. I-123-MIBG imaging is an appropriate approach to evaluate non-invasively not only cardiac sympathetic nervous activity, but also latent ongoing myocardial damage in the failing heart.